Last updated: September 2, 2023
Sponsor: Tanta University
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Peri-capsular nerve group block
anterior suprascapular nerve block
interscalene nerve block
Clinical Study ID
NCT05739201
36264MS18/1/23
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adult patients.
- ASA class I and II and scheduled for elective shoulder arthroscopy.
Exclusion
Exclusion Criteria:
- Patient who refuses the regional anesthesia technique.
- History of allergy to local anesthetics.
- Local infection at the site of the block.
- History of Pre-existing major organ dysfunction such as hepatic and renal failure.
- History of pre-existing lung disease (COPD, uncontrolled asthma).
- Preexisting upper extremity neurological abnormality or neuropathy.
- Difficulties in comprehending (NRS).
- Chronic opioid users (opioid intake more than 3 months).
Study Design
Total Participants: 90
Treatment Group(s): 3
Primary Treatment: Peri-capsular nerve group block
Phase:
Study Start date:
February 20, 2023
Estimated Completion Date:
December 20, 2023
Study Description
Connect with a study center
Shrouk Mohamed Elsawaf
Tanta, EL-Gharbia 31527
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.